respivax

Known as: respivaks 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2009
0119892009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Respivax (BulBio-NCIPD Ltd.) is an oral polybacterial immunomodulator intended for treatment and prevention of non-specific… (More)
Is this relevant?
Review
2004
Review
2004
During 20 years different oral immunostimulators have been developed and tested in the National Center of Infectious and… (More)
Is this relevant?
1991
1991
The antimetastatic activity of orally administered polybacterial vaccines, Broncho-Vaxom (BV) and Respivax (RV) was examined in… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
1989
1989
Several immunostimulating drugs--levamisole (decaris), Gamma-A, dipyridamole (Antistenocardin), Respivax--were included in the… (More)
Is this relevant?